Forensic Science International
Volume 115, Issue 3 , Pages 219-229 , 15 January 2001

Numerical density of μ opioidreceptor expressing neurons in the frontal cortex of drug related fatalities

  • P Schmidt

      Affiliations

    • Institute of Forensic Medicine, Rheinische-Friedrich-Wilhelms-University of Bonn, Stiftsplatz 12, 53111 Bonn, Germany
    • ,
  • C Schmolke

      Affiliations

    • Rheinische Kliniken Bonn, Kaiser-Karl-Ring 20, 53111 Bonn, Germany
    • ,
  • F Mußhoff

      Affiliations

    • Institute of Forensic Medicine, Rheinische-Friedrich-Wilhelms-University of Bonn, Stiftsplatz 12, 53111 Bonn, Germany
    • ,
  • C Prohaska

      Affiliations

    • Institute of Forensic Medicine, Rheinische-Friedrich-Wilhelms-University of Bonn, Stiftsplatz 12, 53111 Bonn, Germany
    • ,
  • M Menzen

      Affiliations

    • Institute of Forensic Medicine, Rheinische-Friedrich-Wilhelms-University of Bonn, Stiftsplatz 12, 53111 Bonn, Germany
    • ,
  • B Madea

      Affiliations

    • Institute of Forensic Medicine, Rheinische-Friedrich-Wilhelms-University of Bonn, Stiftsplatz 12, 53111 Bonn, Germany
    • Corresponding Author InformationCorresponding author. Fax: +49-228-738339

Received 22 October 1999 ,Revised 12 June 2000 ,Accepted 15 June 2000.

References 

  1. Knapp RJ, Malatynska E, Collins N, Fang L, Wang JY, Hruby VJ, et al. Molecular biology and pharmacology of cloned opioid receptors. FASEB J. 1995;9:516–525
  2. Reisine T. Review: neurotransmitter receptors. V. Opiate receptors. Neuropharmacology. 1995;34:463–4725
  3. Matthes HW, Maldonado R, Simonon F, Valverde O, Slowe S, Kitchen I, et al. Loss of morphine induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 1996;383:819–823
  4. Werling LL, McMahon PN, Cox BM. Selective changes in μ opioid receptor properties induced by chronic morphine exposure. Proc. Natl. Acad. Sci. U.S.A. 1989;86:6393–6397
  5. Puttfarcken PS, Cox BM. Morphine-induced desensitization and down-regulation at μ-receptors in 7315C pituitary tumor cells. Life Sci. 1989;45:1937–1942
  6. Pert CB, Pasternak G, Snyder SH. Opiate agonists and antagonists discriminated by receptor binding in brain. Science. 1973;182:1359–1361
  7. Brady LS, Herkenham M, Long JB, Rothman RB. Chronic morphine increases μ-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 1989;477:382–386
  8. Bolger GT, Skolnick P, Rice KC, Weissman BA. Differential regulation of μ-opiate receptors in heroin- and morphine-dependent rats. FEBS Lett. 1988;234:22–26
  9. Arvidsson U, Riedl M, Chakrabarti S, Lee J-H, Nakano AH, Dado RJ, et al. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 1995;15:3328–3341
  10. P. Schmidt, C. Schmolke, F. Musshoff, M. Menzen, C. Prohaska, B. Madea, Immunhistochemische Darstellung des μ-Opioidrezeptors im menschlichen Frontalcortex, in: K. Püschel (Hrsg.) Referate der 8. Frühjahrstagung - Region Nord - der Deutschen Gesellschaft für Rechtsmedizin, Hamburg, 1999, p. 25.
  11. K. Brodmann, Vergleichende Lokalisationslehre der Großhirnrinde, Johann Ambrosius Barth, Leipzig, 1909.
  12. Kaa E, Teige B. Drug-related deaths during the 1980s. A comparative study of drug addict deaths examined at the institutes of forensic medicine in Aarhus, Denmark and Oslo, Norway. Int. J. Leg. Med. 1993;106:5–9
  13. Skopp G, Lutz R, Ganßmann B, Mattern R, Aderjan R. Postmortem distribution pattern of morphine and morphine glucuronides in heroin overdose. Int. J. Leg. Med. 1996;109:118–124
  14. Staub C, Jeanmonod R, Fryc O. Morphine in post-mortem blood: its importance for the diagnosis of deaths associated with opiate addiction. Int. J. Leg. Med. 1990;104:39–42
  15. Schmolke C, Künzle H. On the presence of dendrite bundles in the cerebral cortex of the Madagascan lesser hedgehog tenrec and the red-eared turtle. Anat. Embryol. 1997;196:195–213
  16. Schröder H, Giacobini E, Struble RG, Luiten PGM, Zee EAVD, Zilles K, et al. Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer’s disease. Brain Res. Bull. 1991;27:631–636
  17. Coggeshall RE, Lekan HE. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J. Comp. Neurol. 1996;364:6–15
  18. Delfs JM, Kong H, Mestek A, Chen Y, Yu L, Reisine T, et al. Expression of μ opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. J. Comp. Neurol. 1994;345:46–68
  19. Mansour A, Fox CA, Thompson RC, Akil H, Watson SJ. μ opioid receptor mRNA expression in the rat CNS: comparison to μ-receptor binding. Brain Res. 1994;643:245–265
  20. Mansour A, Fox CA, Akil H, Watson SJ. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995;18:22–29
  21. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. TIPS. 1992;13:177–184
  22. Di Chiara G. Neurobiology of opiate abuse. TIPS. 1992;13:185–193
  23. Hiller JM, Fan L-Q. Laminar distribution of the multiple opioid receptors in the human cerebral cortex. Neurochem. Res. 1996;21:1333–1345
  24. Mansour A. Anatomy of CNS opioid receptors. Trends Neurosci. 1988;11:308–314
  25. Rogers NF, El-Fakahany EE. Morphine-induced receptor down-regulation detected in intact adult rat brain cells. Eur. J. Pharmacol. 1986;124:221–230
  26. Klee WA, Streaty RA. Narcotic receptor sites in morphine-dependent rats. Nature. 1974;248:61–63
  27. Brunello N, Volterra A, Di Giulio AM, Cuomo V, Racagni G. Modulation of opioid system in C57 mice after repeated treatment with morphine and naloxone: biochemical and behavioral correlates. Life Sci. 1984;34:1669–1678
  28. Geary WA, Wooten GF. Regional saturation studies of [3H]naloxone binding in the naive, dependent and withdrawal states. Brain Res. 1985;360:214–223
  29. Sharma SK, Klee WA, Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U.S.A. 1975;72:3092–3096
  30. Lenoir D, Barg J, Simantov R. Down-regulation of opiate receptors in serum-free cultures of aggregating fetal brain cells. Life Sci. 1983;33:337–340
  31. Maloteaux JM, Octave JN, Laterre EC, Laduron PM. Down-regulation of 3H-lofentanil binding sites to opiate receptors in different cultured neuronal cells. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1989;339:192–199
  32. Gabilondo AM, Meana JJ, Barturen F, Sastre M, Garcia-Sevilla JA. μ-opioid receptor and α2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts. Psychopharmacology. 1994;115:135–140
  33. Morris BJ, Herz A. Control of opiate receptor number in vivo: simultaneous κ-receptor down-regulation and μ-receptor up-regulation following chronic agonist/antagonist treatment. Neuroscience. 1989;29:433–442
  34. Tao P-L, Law P-Y, Loh HH. Decrease in δ and μ opioid receptor binding capacity in rat brain after chronic etorphine treatment. J. Pharmacol. Exp. Ther. 1987;240:809–816
  35. Zukin RS, Sugarman JR, Fitz-Syage ML, Gardner EL, Zukin SR, Gintzler AR. Naltrexone-induced opiate receptor supersensitivity. Brain Res. 1982;245:285–292

☆ Dedicated to Prof. Dr. med. W. Bonte, on the occasion of his 60th birthday.

PII: S0379-0738(00)00333-9

Forensic Science International
Volume 115, Issue 3 , Pages 219-229 , 15 January 2001

Article Tools

* Image Usage & Resolution